NCT06469710 A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients Status NOT_YET_RECRUITING Phase N/A
NCT06468332 Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer Status RECRUITING Phase N/A
NCT06465966 UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning Status RECRUITING Phase NA
NCT06465069 A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors Status RECRUITING Phase PHASE1
NCT06463457 Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06462963 OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT) Status RECRUITING Phase NA
NCT06462508 Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis Status RECRUITING Phase EARLY_PHASE1
NCT06462495 Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis Status RECRUITING Phase EARLY_PHASE1
NCT06462014 Description of Relugolix Use in Patients With Prostate Cancer Within the VHA Status COMPLETED Phase N/A
NCT06461416 A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework Status COMPLETED Phase NA
NCT06460454 PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing Status COMPLETED Phase N/A
NCT06458855 Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy Status ACTIVE_NOT_RECRUITING Phase NA
NCT06457919 A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06453785 Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection Status NOT_YET_RECRUITING Phase NA
NCT06451497 This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06451445 A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer Status RECRUITING Phase NA
NCT06450106 Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy Status RECRUITING Phase PHASE1
NCT06449781 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer Status RECRUITING Phase PHASE2